Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Gene Ther ; 23(3): 272-82, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26704722

ABSTRACT

Direct gene delivery to the neurons of interest, without affecting other neuron populations in the cerebral cortex, represent a challenge owing to the heterogeneity and cellular complexity of the brain. Genetic modulation of corticospinal motor neurons (CSMN) is required for developing effective and long-term treatment strategies for motor neuron diseases, in which voluntary movement is impaired. Adeno-associated viruses (AAV) have been widely used for neuronal transduction studies owing to long-term and stable gene expression as well as low immunoreactivity in humans. Here we report that AAV2-2 transduces CSMN with high efficiency upon direct cortex injection and that transduction efficiencies are similar during presymptomatic and symptomatic stages in hSOD1(G93A) transgenic amyotrophic lateral sclerosis (ALS) mice. Our findings reveal that choice of promoter improves selectivity as AAV2-2 chicken ß-actin promoter injection results in about 70% CSMN transduction, the highest percentage reported to date. CSMN transduction in both wild-type and transgenic ALS mice allows detailed analysis of single axon fibers within the corticospinal tract in both cervical and lumbar spinal cord and reveals circuitry defects, which mainly occur between CSMN and spinal motor neurons in hSOD1(G93A) transgenic ALS mice. Our findings set the stage for CSMN gene therapy in ALS and related motor neuron diseases.


Subject(s)
Dependovirus/genetics , Genetic Vectors/therapeutic use , Motor Cortex/metabolism , Motor Neuron Disease/genetics , Motor Neuron Disease/therapy , Transduction, Genetic , Animals , Animals, Genetically Modified , Genetic Therapy , Mice , Motor Neurons/metabolism
2.
J Comp Neurol ; 438(4): 377-87, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11559894

ABSTRACT

Nerve growth factor (NGF) and related neurotrophins induce differential axon growth patterns from embryonic sensory neurons (Lentz et al. [1999] J. Neurosci. 19:1038-1048; Ulupinar et al. [2000a] J. Comp. Neurol 425:622-630). In wholemount explant cultures of embryonic rat trigeminal ganglion and brainstem or in dissociated cell cultures of the trigeminal ganglion, exogenous supply of NGF leads to axonal elongation, whereas neurotrophin-3 (NT-3) treatment leads to short branching and arborization (Ulupinar et al. [2000a] J. Comp. Neurol. 425:622-630). Axonal responses to neurotrophins might be mediated via the Rho GTPases. To investigate this possibility, we prepared wholemount trigeminal pathway cultures from E15 rats. We infected the ganglia with recombinant vaccinia viruses that express GFP-tagged dominant negative Rac, Rho, or constitutively active Rac or treated the cultures with lysophosphatitic acid (LPA) to activate Rho. We then examined axonal responses to NGF by use of the lipophilic tracer DiI. Rac activity induced longer axonal growth from the central trigeminal tract, whereas the dominant negative construct of Rac eliminated NGF-induced axon outgrowth. Rho activity also significantly reduced, and the Rho dominant negative construct increased, axon growth from the trigeminal tract. Similar alterations in axonal responses to NT-3 and brain-derived neurotrophic factor were also noted. Our results demonstrate that Rho GTPases play a major role in neurotrophin-induced axonal differentiation of embryonic trigeminal axons.


Subject(s)
Genetic Vectors/physiology , Growth Cones/ultrastructure , Nerve Growth Factors/pharmacology , Neurons, Afferent/cytology , Trigeminal Ganglion/embryology , rho GTP-Binding Proteins/metabolism , Afferent Pathways/drug effects , Afferent Pathways/embryology , Afferent Pathways/enzymology , Animals , Brain-Derived Neurotrophic Factor/metabolism , Brain-Derived Neurotrophic Factor/pharmacology , Carbocyanines/pharmacokinetics , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Size/drug effects , Cell Size/physiology , Fetus , Fluorescent Dyes/pharmacology , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Growth Cones/drug effects , Growth Cones/enzymology , Immunohistochemistry , Lysophospholipids/pharmacology , Nerve Growth Factor/metabolism , Nerve Growth Factor/pharmacology , Nerve Growth Factors/metabolism , Neurons, Afferent/drug effects , Neurons, Afferent/enzymology , Neurotrophin 3/metabolism , Neurotrophin 3/pharmacology , Rats , Rats, Sprague-Dawley , Transfection , Trigeminal Ganglion/drug effects , Trigeminal Ganglion/enzymology , Trigeminal Nuclei/drug effects , Trigeminal Nuclei/embryology , Trigeminal Nuclei/enzymology , Vaccinia virus/genetics , rac GTP-Binding Proteins/drug effects , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/metabolism , rho GTP-Binding Proteins/drug effects , rho GTP-Binding Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL